Published in Blood Weekly, September 1st, 1997
Eric J. Topol, M.D., from the Cleveland Clinic Foundation, Ohio, and colleagues found a 19 percent reduction in the risk of death, heart attack, and need to re-open the arteries after the first year with use of abciximab when compared with placebo. At three years, there was a 13 percent reduction.
Their study was published in the August 13, 1997 issue of The Journal of the American Medical Association.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.